{"id":"erythromycin-azithromycin-clarithromycin","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Gastrointestinal disturbance (nausea, vomiting, diarrhea)"},{"rate":"5-15","effect":"Abdominal pain"},{"rate":"2-5","effect":"Headache"},{"rate":"1-3","effect":"QT prolongation"},{"rate":"1-2","effect":"Hepatotoxicity"},{"rate":"1-3","effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Erythromycin, azithromycin, and clarithromycin are macrolide antibiotics that bind reversibly to the bacterial 50S ribosomal subunit, blocking peptide translocation and inhibiting protein synthesis. This bacteriostatic action prevents bacterial growth and reproduction. They are effective against a broad spectrum of gram-positive and some gram-negative bacteria, as well as atypical organisms.","oneSentence":"These macrolide antibiotics inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:29:33.636Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Respiratory tract infections (pneumonia, bronchitis)"},{"name":"Skin and soft tissue infections"},{"name":"Sexually transmitted infections (chlamydia, gonorrhea)"},{"name":"Otitis media"},{"name":"Streptococcal pharyngitis"},{"name":"Mycobacterial infections (MAC prophylaxis in HIV)"}]},"trialDetails":[{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT06396078","phase":"PHASE4","title":"Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-18","conditions":"Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth","enrollment":56},{"nctId":"NCT03236987","phase":"PHASE3","title":"CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2018-02-05","conditions":"Lung Infection, MAC Lung Disease","enrollment":424},{"nctId":"NCT07148622","phase":"NA","title":"Effects of Different Antibiotic Regimens in Preterm Premature Rupture of Membranes","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2024-10-01","conditions":"Preterm Premature Rupture of Membranes (PPROM), Prophylaxis, Perinatal Outcomes","enrollment":40},{"nctId":"NCT04310930","phase":"PHASE2, PHASE3","title":"Finding the Optimal Regimen for Mycobacterium Abscessus Treatment","status":"RECRUITING","sponsor":"The University of Queensland","startDate":"2020-03-02","conditions":"Pulmonary Disease Due to Mycobacteria (Diagnosis)","enrollment":300},{"nctId":"NCT06207786","phase":"NA","title":"Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2024-09-01","conditions":"Skin Cancer, Skin Cancer Face, Malignant Cutaneous Adnexal Neoplasm","enrollment":""},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT04622891","phase":"NA","title":"Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection","status":"COMPLETED","sponsor":"South Valley University","startDate":"2020-04-01","conditions":"Covid19","enrollment":300},{"nctId":"NCT03948620","phase":"","title":"Macrolide in Pregnancy and Adverse Child Outcomes","status":"COMPLETED","sponsor":"Institute of Child Health","startDate":"1990-01-01","conditions":"Infection","enrollment":726274},{"nctId":"NCT03571230","phase":"PHASE4","title":"Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2018-07-01","conditions":"Helicobacter Pylori Infection, Antimicrobial Susceptibility Testing","enrollment":400},{"nctId":"NCT02068170","phase":"","title":"Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital","status":"COMPLETED","sponsor":"KU Leuven","startDate":"2014-02","conditions":"Delirium, QT-prolongation","enrollment":178},{"nctId":"NCT00717561","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-02","conditions":"Pneumonia","enrollment":60},{"nctId":"NCT02171338","phase":"PHASE4","title":"Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections","status":"UNKNOWN","sponsor":"Holbaek Sygehus","startDate":"2013-10","conditions":"Pneumonia, Acute Exacerbation of Chronic Obstructive Airways Disease","enrollment":55},{"nctId":"NCT00001023","phase":"NA","title":"The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Mycobacterium Avium-intracellulare Infection, HIV Infections","enrollment":91},{"nctId":"NCT01667692","phase":"PHASE4","title":"Aizthromycin or Clarithromycin in H-pylori Eradication Regimen","status":"COMPLETED","sponsor":"Shahid Sadoughi University of Medical Sciences and Health Services","startDate":"2011-03","conditions":"Peptic Ulcer, Dyspepsia, H-pylori","enrollment":78},{"nctId":"NCT00368342","phase":"PHASE4","title":"Chronic Bronchiolitis or Resistant Asthma?","status":"COMPLETED","sponsor":"Baqiyatallah Medical Sciences University","startDate":"","conditions":"Asthma","enrollment":""},{"nctId":"NCT00354952","phase":"NA","title":"Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Oral Flora","status":"COMPLETED","sponsor":"Universiteit Antwerpen","startDate":"2002-07","conditions":"Healthy Volunteers","enrollment":203},{"nctId":"NCT00002140","phase":"PHASE3","title":"A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients","status":"COMPLETED","sponsor":"Pfizer","startDate":"","conditions":"Mycobacterium Avium-intracellulare Infection, HIV Infections","enrollment":""},{"nctId":"NCT00002192","phase":"PHASE2","title":"Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.","status":"COMPLETED","sponsor":"Anderson Clinical Research","startDate":"","conditions":"Mycobacterium Avium-Intracellulare Infection, HIV Infections","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Erythromycin, Azithromycin , Clarithromycin","genericName":"Erythromycin, Azithromycin , Clarithromycin","companyName":"Baqiyatallah Medical Sciences University","companyId":"baqiyatallah-medical-sciences-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"These macrolide antibiotics inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit. Used for Respiratory tract infections (pneumonia, bronchitis), Skin and soft tissue infections, Sexually transmitted infections (chlamydia, gonorrhea).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}